X0306 4/A 2018-06-14 2018-06-18 0 0001314102 EyePoint Pharmaceuticals, Inc. EYPT 0001458753 Ross Leonard S C/O EYEPOINT PHARMACEUTICALS, INC. 480 PLEASANT STREET WATERTOWN MA 02472 0 1 0 0 See Remarks Restricted Stock Units 2018-06-14 4 A 0 24840 0.00 A Common Stock 24840 24840 D Stock Option (right to buy) 2.04 2018-06-14 4 A 0 99360 0.00 A 2028-06-14 Common Stock 99360 99360 D Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The restricted stock units will vest in three equal annual installments beginning June 14, 2019. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. The option to purchase will vest and become exercisable in three equal annual installments beginning June 14, 2019. VP, Finance and Chief Accounting Officer This form is being filed to correct the number of restricted stock units and stock options awarded to the reporting person. /s/ John Mercer, Attorney-in-Fact 2018-06-22